Biologic Augmentation of TMJ Arthroscopy Using BMAC
Start Date
5/1/2026
Completion Date
6/1/2028
Summary
The goal of this clinical trial is to learn about the efficacy of using Bone Marrow Aspirate Concentrate (BMAC) during temporomandibular joint (TMJ) arthroscopy compared to standard arthroscopic procedures with corticosteroid (CS) injections in patients with pain (arthralgia) of the temporomandibular joint (TMJ) that has failed to respond to conservative treatment. The main question it aims to answer: Does BMAC injection reduce the amount of inflammation and structural damage in the TMJ? Researchers will compare BMAC injection to corticosteroid injections see if BMAC injection helps . Participants will : * Be randomized to receive either BMAC or CS injection during TMJ arthroscopy * Visit the clinic for 3 follow up visits over 6 months and answer questionnaires * have 2 MRIs of their jaw
Eligibility Criteria
Age Range: 18 years to 75 years
Interventions
Bone Marrow Aspirate Concentrate
Corticosteroid (CS)
Conditions
Locations
Weill Cornell Medical College - NewYork-Presbyterian Hospital
New York, New York 10024
United States